MOH monthly performance report
Check MOH's monthly returns, drawdown, and seasonality trends — updated every month.
MOH monthly report
—
Key takeaways
- Molina Healthcare (MOH) closed November 2026 at $209.49, up 2.30% for the month and +51.28% over the trailing 12 months.
- Year-to-date, MOH is +20.72%, outperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +12.73% versus its 200-day moving average ($185.84), a bullish technical signal.
- Over the past three years, MOH has underperformed the S&P 500 by −113.36%, with a relative strength index reading of 33.8.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Molina Healthcare ended November 2026 at $209.49, posting a monthly return of +2.30%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +2.48%.
The current quarter stands at +10.78% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +12.73% versus the 200-day moving average ($185.84).
Year-to-date, MOH is +20.72% against SPY +10.62%, a gap of +10.09%. The stock is currently −14.18% below its 52-week high, with maximum 3-year drawdown at −70.76%.
| Period | MOH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.17% | −0.36% | +0.19% |
| 1 Week | +0.24% | +2.59% | −2.36% |
| 1 Month | +2.30% | −0.18% | +2.48% |
| 3 Months | +3.17% | −2.37% | +5.53% |
| 6 Months | +12.15% | +0.83% | +11.32% |
| YTD | +20.72% | +10.62% | +10.09% |
| 12 Months | +51.28% | +12.25% | +39.03% |
| 3 Years | −41.99% | +71.37% | −113.36% |
| Rank | Month | Return |
|---|---|---|
| #1 | Apr 2026 | +46.00% |
| #2 | Jun 2026 | +31.74% |
| #3 | Dec 2025 | +17.05% |
| #4 | Jul 2024 | +14.79% |
| #5 | Aug 2025 | +14.54% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2025 | −47.01% |
| #2 | Oct 2025 | −20.01% |
| #3 | Apr 2024 | −16.73% |
| #4 | Jul 2026 | −14.46% |
| #5 | Feb 2026 | −14.22% |
| Quarter | Return |
|---|---|
| Q3 2025 | −35.76% |
| Q4 2025 | −9.31% |
| Q1 2026 | −23.19% |
| Q2 2026 | +71.57% |
| Q3 2026 | −17.32% |
| Q4 2026 (QTD) | +10.78% |
| Year | Return |
|---|---|
| 2023 | +9.41% |
| 2024 | −19.45% |
| 2025 | −40.37% |
| 2026 | +20.72% |
| Metric | Value |
|---|---|
| 52-Week High | $244.11 (2026-07-14) |
| 52-Week Low | $121.06 (2026-02-11) |
| Current Price | $209.49 |
| 200-Day Moving Average | $185.84 |
| Price vs 200DMA | +12.73% |
| 3-Year Maximum Drawdown | −70.76% (2026-02-11) |
| Current Drawdown from 52W High | −14.18% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 33.8 |
| 3-Year Excess Return vs S&P 500 | −113.36% |
| RS Peak | 100 (Nov 2023) |
| RS Trough | 21.6 (Feb 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MOH's return for this report period?
MOH returned +2.30% in the latest monthly window ending 2026-11-13.
Has MOH outperformed SPY year to date?
YTD MOH: +20.72% vs SPY: +10.62%.
What is MOH's 12-month return?
+51.28% over the trailing 12 months.
Is MOH above or below its 200-day moving average?
Price is +12.73% versus 200DMA ($185.84).
What is the maximum drawdown in the 3-year window?
−70.76% on 2026-02-11.